Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

4'-iodo-4'-deoxydoxorubicin

An iodinated doxorubicin analogue with antiamyloid activity. 4'-Iodo-4'-deoxydoxorubicin (IDOX) binds with high affinity to five types of natural amyloid fibrils including immunoglobulin light chains, amyloid A, transthyretin (methionine-30 variant), beta-protein (Alzheimer), and beta2-microglobulin. This agent may inhibit fibril growth, increasing the solubility of amyloid tissue deposits and facilitating their clearance. IDOX has also been shown to insulin amyloid fibrillogenesis in vitro.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:4'-deoxy-4'-iododoxorubicin
iodo-doxorubicin
iododoxorubicin
Abbreviation:IDOX
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search